跳至主要内容
临床试验/ISRCTN10029862
ISRCTN10029862
已完成
未知

Hypnosis for management of breathlessness and anxiety in severe and palliative-care COPD patients: a sham-controlled crossover trial

Bligny Hospital Center0 个研究点目标入组 21 人2020年1月7日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Dyspnea (breathlessness) in patients with severe chronic obstructive pulmonary disease (COPD)
发起方
Bligny Hospital Center
入组人数
21
状态
已完成
最后更新
3年前

概览

简要总结

2020 Results article in https://doi.org/10.2147/COPD.S267019 results (added 23/10/2020) 2022 Protocol article in https://doi.org/10.1183/23120541.00565-2021 (added 28/02/2023)

注册库
who.int
开始日期
2020年1月7日
结束日期
2020年2月20日
最后更新
3年前
研究类型
Interventional
性别
All

研究者

发起方
Bligny Hospital Center

入排标准

入选标准

  • 1\. Aged 35\-80 years
  • 2\. Affiliated to a Social Security scheme or beneficiary of such a scheme
  • 3\. Absence of neurological disease interfering with the passing of tests
  • 4\. Capable of giving free, informed consent.
  • 5\. Severe COPD with dyspnea and distension
  • 6\. Hospitalized, with or without a tracheotomy
  • 7\. Non\-obese
  • 8\. Predicted FEV1 \<60% and FEV/FVC \<70%, with distension evidenced by chest x\-ray or predicted TLC \>120% in pulmonary function tests
  • 9\. Severity marked by ongoing hospitalization, with at least one prior instance of decompensation
  • 10\. Dyspneic, with resting Borg Scale score \=3

排除标准

  • 1\. Pregnancy
  • 2\. Mechanical ventilation during the session
  • 3\. Known severe cardiac insufficiency
  • 4\. Known severe pulmonary arterial hypertension
  • 5\. Cancer diagnosis
  • 6\. Significant cognitive impairment, hypercapnic encephalopathy or confusional syndrome
  • 7\. Deafness
  • 8\. Anemia (hemoglobin \=8 g/dl)
  • 9\. Psychotic pathology
  • 10\. Anti\-epileptic treatment

结局指标

主要结局

未指定

相似试验